R
Rosalba Lembo
Researcher at Vita-Salute San Raffaele University
Publications - 72
Citations - 2287
Rosalba Lembo is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Randomized controlled trial & Intensive care. The author has an hindex of 18, co-authored 63 publications receiving 1556 citations. Previous affiliations of Rosalba Lembo include European Institute of Oncology & Università Campus Bio-Medico.
Papers
More filters
Journal ArticleDOI
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.
Federico Pappalardo,Christian Schulte,Marina Pieri,Benedikt Schrage,Rachele Contri,Gerold Soeffker,Teresa Greco,Rosalba Lembo,Kai Müllerleile,Antonio Colombo,Karsten Sydow,Michele De Bonis,Florian Wagner,Hermann Reichenspurner,Stefan Blankenberg,Alberto Zangrillo,Dirk Westermann +16 more
TL;DR: Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) support stabilizes patients with cardiogenic shock and may be impeded due to the increased afterload, resulting in a failing static left ventricle and in high mortality.
Journal ArticleDOI
Levosimendan for Hemodynamic Support after Cardiac Surgery
Giovanni Landoni,Vladimir V. Lomivorotov,Gabriele Alvaro,Rosetta Lobreglio,Antonio Pisano,Fabio Guarracino,Maria Grazia Calabrò,Evgeny Grigoryev,Valery Likhvantsev,Marcello Fonseca Salgado-Filho,Alessandro Bianchi,Vadim Pasyuga,Massimo Baiocchi,Federico Pappalardo,Fabrizio Monaco,Vladimir A. Boboshko,Marat N Abubakirov,Bruno Amantea,Rosalba Lembo,Luca Brazzi,Luigi Verniero,Pietro Bertini,Anna Mara Scandroglio,Tiziana Bove,Alessandro Belletti,Maria G Michienzi,Dmitriy L Shukevich,Tatiana S. Zabelina,Rinaldo Bellomo,Alberto Zangrillo +29 more
TL;DR: In patients who required perioperative hemodynamic support after cardiac surgery, low‐dose levosimendan in addition to standard care did not result in lower 30‐day mortality than placebo and there was no significant difference in rates of hypotension or cardiac arrhythmias.
Journal ArticleDOI
The Fragility Index in Multicenter Randomized Controlled Critical Care Trials.
Elliott E. Ridgeon,Paul J Young,Rinaldo Bellomo,Marta Mucchetti,Rosalba Lembo,Giovanni Landoni +5 more
TL;DR: In critical care trials reporting statistically significant effects on mortality, the findings often depend on a small number of events, so critical care clinicians should be wary of basing decisions on trials with a low fragility index.
Journal ArticleDOI
Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial
Tiziana Bove,Alberto Zangrillo,Fabio Guarracino,Gabriele Alvaro,Bruno Persi,E Maglioni,Nicola Galdieri,Marco Comis,Fabio Caramelli,Daniela Pasero,Giovanni Pala,Massimo Renzini,Massimiliano Conte,Gianluca Paternoster,Blanca Martinez,Fulvio Pinelli,Mario Frontini,Maria Chiara Zucchetti,Federico Pappalardo,Bruno Amantea,Anna Maria Camata,Antonio Pisano,Claudio Verdecchia,Erika Dal Checco,Claudia Cariello,Luana Faita,Rubia Baldassarri,Anna Mara Scandroglio,Omar Saleh,Rosalba Lembo,Maria Grazia Calabrò,Rinaldo Bellomo,Giovanni Landoni +32 more
TL;DR: Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension.
Journal ArticleDOI
Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery
Giovanni Landoni,Vladimir N. Lomivorotov,Caetano Nigro Neto,Fabrizio Monaco,Vadim Pasyuga,Nikola Bradic,Rosalba Lembo,Gordana Gazivoda,Valery Likhvantsev,Chong Lei,Andrey Lozovskiy,Nora Di Tomasso,Nazar Bukamal,Fernanda Santos Silva,Andrey E Bautin,Ma Jun,Martina Crivellari,Ahmed A. Farag,Nikolay S Uvaliev,Cristiana Carollo,Marina Pieri,Jan Kunstýř,Chew Yin Wang,Alessandro Belletti,Ludhmila Abrahão Hajjar,Evgeny Grigoryev,Felice Eugenio Agrò,Hynek Riha,Mohamed R. El-Tahan,A Mara Scandroglio,Abeer M Elnakera,Massimo Baiocchi,Paolo Navalesi,Vladimir Shmyrev,Luca Severi,Mohammed A Hegazy,Giuseppe Crescenzi,Dmitry Ponomarev,Luca Brazzi,Renato Tambellini Arnoni,Dmitry Tarasov,Miomir Jovic,Maria Grazia Calabrò,Tiziana Bove,Rinaldo Bellomo,Alberto Zangrillo +45 more
TL;DR: Among patients undergoing elective CABG, anesthesia with a volatile agent did not result in significantly fewer deaths at 1 year than total intravenous anesthesia, and the trial was stopped for futility.